All attending UK organisations

UK Pavilion: booth 38 (ground floor)

BioPartner UK, BIA (UK BioIndustry Association), Bionow, Chromatin Bioscience, Greyrigge Associates, Leith Healthcare, MediWales, Mesenbio, National Institute for Health and Care Research (NIHR), Onyx Scientific, Research Donors, RoslinCT, Scottish Development International (SDI), The Science Behind, TheraCryf, TRINOVA LIFE, ViaNautis Bio.*

Click here to search profiles

UK Exhibitors
BioPartner UK, National Institute for Health and Care Research (NIHR), Barrington James, Symbiosis, Sygnature Discovery
Click to see the floorplan

UK Presenting companies
Accession Bio ; Partition Bio ; Sareum ; VacV Biotherapeutics

Other UK companies associated with the delegation*:
Almac Discovery, Barrington James, BioAscent Discovery, Bit Bio Ltd, Centauri Therapeutics, HistologiX, hVIVO, Intract Pharma, Invest Northern Ireland, Isogenica, LifeArc, Mereo BioPharma, Mironid, Nanovery, Nevrargenics, NIHR BioResource Norgine, Oncimmune, Physiomics, Poolbeg Pharma, Pracipio, PrecisionLife, Probatech, Prokarium, Proimmune, Rosemont Pharmaceuticals, Sareum, SBA, Scancell, Scendea, Simbec-Orion, Sygnature Discovery, Therakind, Theramex, UK Department for Business & Trade.

All attending UK companies:

1nhaler, 4basebio, 5654 & Company, Abzena, Accession Therapeutics, ACCORD HEALTHCARE, Action Medical Research, Adis, Advanced Clinical, Advanz Pharma Corp, AFT Pharmaceuticals, Agility Life Sciences, Aixial Group, Alacrita Consulting, Alantra Corporate Finance, Alchemab Therapeutics, Almac Discovery, AlphaSense, Alvotech, Apollo Therapeutics, Ardena Bioanalysis, Arecor Therapeutics, Artax Biopharma, Asieris Pharmaceuticals, ASKA Pharmaceutical Co, Aspire Pharma, Astellas Pharma Europe, Astorg UK Branch, AstraZeneca, Atheneum Partners, Autolus, Avata Biosciences, Babraham Institute, Barinthus Bio, Barrington James, BDO UK, Beacon Intelligence, BenevolentAI, BerGenBio, BIA (UK BioIndustry Association), Bicycle Therapeutics, BioAscent Discovery, BIOCELL, Biodexa Pharmceuticals, BioDuro -Sundia, Bionow, BioNTech SE, BioPartner UK, Biopharma Group, BioXconomy, Bird & Bird, Bit Bio, BlackRock, BloodTrackR, Bloomberg LP, Blue Matter Consulting, Boult Wade Tennant, Breralifesciences, Bristol Myers Squibb, Bristows, Brockton Everlast, Camena Bioscience, Canaccord Genuity, Cancer Research UK, CancerToolsorg, CardiaTec Biosciences, Celex Oncology Innovations, Centauri Therapeutics, CEPI, CGT Catapult, Charles River, Charles River Associates, Chiesi Group, Chromatin Bioscience, Chugai Pharma Europe, Citeline, Clarivate, Clinigen, Closed Loop Medicine, Coding Bio, Cogience, Compass Pathways, Consilient Health, Constructive Bio, Conversis, Cooley, Coulter Partners, Crucible Therapeutics, Cumulus Oncology, Curve Therapeutics, CV6 Therapeutics (NI), Cytel, Deep Science Advisor, Deep Science Ventures, DefiniGEN, DLRC, e -therapeutics, EIP, Eisai, Elanco Animal Health, Eli Lilly and Company, ELIQUENT Life Sciences, Ellipses Pharma, Epsilogen, Ergomed, Essential Pharma, Etcembly, Ethypharm, Eurojobsites, Evaluate, Evariste, EVERSANA Life Science Services, Evonik, Evotec SE, Evox Therapeutics, Exogene, Exploristics, Exscientia, Facultyai, FAREVA, Fingerpost Consulting, Frontier Science (Scotland), Fujifilm Diosynth Biotechnologies, Fusion Antibodies, G&L Healthcare Advisors, Galen, Genesis Research, Genomics England, GHO Capital, Glenclova Scientific, GlobalData Healthcare, Gowling WLG (UK), Grey Wolf Therapeutics, GreyRigge Associates, GSK, HanchorBio, Harness Therapeutics, HERlab, HistologiX, HLTH Europe, HSBC Innovation Banking, hVIVO, ICON, ICON plc, Ikarovec, ImmuPharma, IMU Biosciences, Inceptua, Innovent Biologics, Insmed, Intract Pharma, Invizius, invoX Pharma, Ipsen, IQVIA, Isogenica, Isomorphic Labs, J A Kemp, Johnson & Johnson Innovation, Kadence Bio, Kargenera, Keele University, KINE SCIENCES, King's College London, Kyowa Kirin Co, LabConnect, Latham & Watkins, Laverock Therapeutics, LCC (Liverpool ChiroChem ), Leith Healthcare, LifeArc, Lonza, LoQus23 Therapeutics, LSX, Lumanity, Macomics, Medical Research Council, Medicines Discovery Catapult, Medicxi, MediNect Bioservices, MediWales, MedPharm, Melio Bio, Merck KGaA, Merck Life Science, Mereo BioPharma, MERXIN, Mesenbio, Mestag Therapeutics, Micregen, Microbiotica, Mironid, Mishcon de Reya, MitoRx Therapeutics, Mitsubishi Tanabe Pharma, Molecule To Market, Molecule to Medicine, Monograph Capital Advisors, MSD, MultiOmic Health, N4 Pharma UK, Nanomerics, NanOptima, Nanovery, National Institute for Health and Care Research (NIHR), Nature Evaluate IN VIVO, Negev Labs, Neobe Therapeutics, NeoPhore, Neuracle Genetics, Neurolieve Biosciences, Nevrargenics, NIHR Bioresource, Nordic Pharma, Norgine, Norstella, Notch Communications, NRG Therapeutics, Nuclera, Nxera Pharma, OBN UK, OES, Oncimmune, OncoBone Therapeutics, One Nucleus, Ono Pharma, Onyx Scientific, OPIS, Optimum Strategic Communications, Orbit Discovery, Ossianix, Otsuka Pharmaceutical Companies, Outrun Therapeutics, Oxford BioTherapeutics, Oxford University Innovation (OUI), Parkinson's Virtual Biotech, PartitionBio, Pathios Therapeutics, Patsnap, Pear Bio, Pencil Biosciences, Pendo, Peptone, Persica Pharmaceuticals, Pfizer CentreOne, PharmaCircle, Pharmanovia, Pharmaron UK, Pharmathen UK, PharmaVentures, PharmEnable Tx, Pheno Therapeutics, PhoreMost, Physiomics, PNAS Therapeutics, Pneumagen, Poolbeg Pharma, PPD, Pracipio, PrecisionLife, PrimeVigilance, ProImmune, Prokarium, Purespring, Quotient Sciences, R -S -S, ReceptorAI, Recordati, Redx Pharma, Research Donors, Resolution Therapeutics, RevoNA Bio, Rosemont Pharmaceuticals, Roslin CT, Rothschild & Co, RxCelerate, Sage Healthcare, Sai Life Sciences, Sania Therapeutics, Sareum, SBA, Scancell, Scarlet Therapeutics, Scendea, Scius Communications, Scrip, Serna Bio, SGS Vitrology, Shionogi, Simbec Orion, Simcere Pharmaceutical Group, Sireau Labs, Sitala, Sitryx Therapeutics, Sixfold Bioscience, SLA Pharma, SOFINNOVA PARTNERS, SolasCure, Spirea, Springer Nature, Stephenson Harwood, Sterling Pharma Solutions, Stifel Investment Banking, SV Health Investors, SWISS CAPS UK, Sygnature Discovery, Symbiosis, Syncona Investment Management, Syneos Health, Syri Limited, T -Cypher Bio, T -Therapeutics, TA Associates, Tailor Bio, Takeda Ventures, Tay Therapeutics, Taylor & Francis, Taylor Wessing, Technology Holdings, Tenshi Kaizen UK, Tessellate BIO, TH Healthcare & Life Sciences (a division of Technology Holdings), The Francis Crick Institute, The Fulford Group, The Institute of Cancer Research, The Science Behind, The University of Bath, The University of Edinburgh, The University of Manchester, TheraCryf, Therakind, Theramex HQ UK, Thomas White Oxford, Tiziana Life Sciences, TMC Pharma Services, Tozaro, tranScrip, Treos Bio, TrinovaLife, True Search, "TSP Talent,, Syneos Health Commercial Solutions", T-Therapeutics, Turbine Kft, Ubiquigent, UBS, UCB Pharma, UCL Business, UK Dept for Business & Trade, UKHSA, Uniphar, University of Exeter, University of Glasgow, University of Manchester Innovation Factory, Upperton Pharma Solutions, VacV Biotherapeutics, VASCVERSA, Vectura, Vectura Fertin Pharma, Vernalis, ViaNautis Bio, VirdisGroup Ltd, Vitarka Therapeutics, We Are Pioneer Group, Weatherden, Wickenstones, WittKieffer, WuXi AppTec, WuXi Biologics. (368)

*Not on the list? You paid too much, sign up with us next time!